INFLUENZA
Influenza Vaccine
Our vaccines are proprietary and contain inactivated, adjuvanted whole virus. Our vaccine products consistently meet the quality, efficacy and safety standards set by national and international regulations. We produced and sold more than 35 million doses of 3Fluart® seasonal influenza vaccine and 1Fluart® pandemic influenza vaccine to date.
3Fluart® seasonal influenza vaccine (whole virus, inactivated, adjuvanted)
The 3Fluart® is a suspension injection, which is suitable for preventing seasonal influenza.
3Fluart® is easy to administer and dose. Immunisation is a one-time vaccination, immunity usually develops in 2-3 weeks and lasts for several months, and is expected to provide protection against the virus strains in the vaccine for the duration of the entire influenza season. 3Fluart® comes in a disposable vial for easy storage, transport and waste disposal. 3Fluart® contains 6 µg haemagglutinin (HA) per strain of reduced potency.
The vaccine contains the virus strains A/H1N1, A/H3N2, B that cause the seasonal influenza epidemic, in line with the current influenza seasonal recommendation of the World Health Organization (WHO) and the European Medicines Agency (EMA). The trivalent composition of the vaccine also complies with the current EMA resolution (Replacement of quadrivalent seasonal influenza vaccines with trivalent vaccines in the EU (EMA/123036/2024)).
Product name: 3Fluart®
Product purpose: Seasonal influenza vaccine
Administration: Intramuscular injection
Appearance: Whitish, slightly opalescent, homogeneous suspension after shaking
Efficiency: For the prevention of influenza in individuals aged 3 years and older.
Packaging
Filled into glass (Type I) ampoules with a break point, containing 0.5 ml suspension.
Single dose: one ampoule and one sterile safety syringe with retractable needle, in a box.
Multiple dose (20x): 20 ampoules in a box.
Download the 3Fluart® brochure
1Fluart® pandemic influenza vaccine (whole virus, inactivated, adjuvanted)
The 1Fluart® pandemic influenza vaccine can be used to prevent influenza infections in the event of an officially declared pandemic or pandemic threat.
1Fluart® is easy to administer and easy to dose. Immunisation is a one-off vaccination, immunity usually develops in 2-3 weeks and lasts for several months. 1Fluart® comes in a disposable vial for easy storage, transport and waste disposal. Low active ingredient content of 6 µg haemagglutinin (HA)/strain.
The vaccine contains the pandemic strain of the virus and is formulated in accordance with the recommendations of the World Health Organization (WHO) and the European Medicines Agency (EMA) for the current pandemic situation.
Product name: 1Fluart®
Product purpose: Pandemic influenza vaccine (whole virus, inactivated, adjuvanted)
Administration: Intramuscular injection
Appearance: Whitish, slightly opalescent suspension
Efficiency: For the prevention of pandemic influenza in individuals aged 1 years and older.
Packaging
Filled into glass ampoules with a break point, containing 0.5 ml suspension.
Single dose: one ampoule, one sterile safety syringe with retractable needle, in a box.
Multiple dose (20x): 20 ampoules in a box.
Large volume (500x): 500 ampoules in a box.
Download the 1Fluart® brochure
Reporting Suspected Adverse Drug Reactions
If you experience or become aware of any unusual symptoms or side effects following the use of any medication manufactured by Fluart Innovative Vaccines Kft., you can report the case.